These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Development and in vitro evaluation of a vaginal microbicide gel formulation for UAMC01398, a novel diaryltriazine NNRTI against HIV-1. Grammen C, Ariën KK, Venkatraj M, Joossens J, Van der Veken P, Heeres J, Lewi PJ, Haenen S, Augustyns K, Vanham G, Augustijns P, Brouwers J. Antiviral Res; 2014 Jan; 101():113-21. PubMed ID: 24269474 [Abstract] [Full Text] [Related]
3. Characteristics of a group of nonnucleoside reverse transcriptase inhibitors with structural diversity and potent anti-human immunodeficiency virus activity. Yang SS, Fliakas-Boltz V, Bader JP, Buckheit RW. Leukemia; 1995 Oct; 9 Suppl 1():S75-85. PubMed ID: 7475321 [Abstract] [Full Text] [Related]
4. Novel diarylpyrimidines and diaryltriazines as potent HIV-1 NNRTIs with dramatically improved solubility: a patent evaluation of US20140378443A1. Huang B, Kang D, Yang J, Zhan P, Liu X. Expert Opin Ther Pat; 2016 Oct; 26(2):281-9. PubMed ID: 26559996 [Abstract] [Full Text] [Related]
15. Inhibition of human immunodeficiency virus type 1 infection by the candidate microbicide dapivirine, a nonnucleoside reverse transcriptase inhibitor. Fletcher P, Harman S, Azijn H, Armanasco N, Manlow P, Perumal D, de Bethune MP, Nuttall J, Romano J, Shattock R. Antimicrob Agents Chemother; 2009 Feb; 53(2):487-95. PubMed ID: 19029331 [Abstract] [Full Text] [Related]
16. Stampidine as a promising antiretroviral drug candidate for pre-exposure prophylaxis against sexually transmitted HIV/AIDS. Uckun FM, Cahn P, Qazi S, D'Cruz O. Expert Opin Investig Drugs; 2012 Apr; 21(4):489-500. PubMed ID: 22360744 [Abstract] [Full Text] [Related]
17. TMC125, a novel next-generation nonnucleoside reverse transcriptase inhibitor active against nonnucleoside reverse transcriptase inhibitor-resistant human immunodeficiency virus type 1. Andries K, Azijn H, Thielemans T, Ludovici D, Kukla M, Heeres J, Janssen P, De Corte B, Vingerhoets J, Pauwels R, de Béthune MP. Antimicrob Agents Chemother; 2004 Dec; 48(12):4680-6. PubMed ID: 15561844 [Abstract] [Full Text] [Related]
18. Novel pyridinone derivatives as non-nucleoside reverse transcriptase inhibitors (NNRTIs) with high potency against NNRTI-resistant HIV-1 strains. Li A, Ouyang Y, Wang Z, Cao Y, Liu X, Ran L, Li C, Li L, Zhang L, Qiao K, Xu W, Huang Y, Zhang Z, Tian C, Liu Z, Jiang S, Shao Y, Du Y, Ma L, Wang X, Liu J. J Med Chem; 2013 May 09; 56(9):3593-608. PubMed ID: 23540737 [Abstract] [Full Text] [Related]
19. Synthesis and biological evaluation of piperidine-substituted triazine derivatives as HIV-1 non-nucleoside reverse transcriptase inhibitors. Chen X, Zhan P, Pannecouque C, Balzarini J, De Clercq E, Liu X. Eur J Med Chem; 2012 May 09; 51():60-6. PubMed ID: 22405288 [Abstract] [Full Text] [Related]
20. 2-(2,6-Dihalophenyl)-3-(pyrimidin-2-yl)-1,3-thiazolidin-4-ones as non-nucleoside HIV-1 reverse transcriptase inhibitors. Rao A, Balzarini J, Carbone A, Chimirri A, De Clercq E, Monforte AM, Monforte P, Pannecouque C, Zappalà M. Antiviral Res; 2004 Aug 09; 63(2):79-84. PubMed ID: 15302136 [Abstract] [Full Text] [Related] Page: [Next] [New Search]